Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

BACKGROUND: Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19) have been associated with an older age. METHO...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:N Engl J Med
Auteurs principaux: Anderson, Evan J., Rouphael, Nadine G., Widge, Alicia T., Jackson, Lisa A., Roberts, Paul C., Makhene, Mamodikoe, Chappell, James D., Denison, Mark R., Stevens, Laura J., Pruijssers, Andrea J., McDermott, Adrian B., Flach, Britta, Lin, Bob C., Doria-Rose, Nicole A., O’Dell, Sijy, Schmidt, Stephen D., Corbett, Kizzmekia S., Swanson, Phillip A., Padilla, Marcelino, Neuzil, Kathy M., Bennett, Hamilton, Leav, Brett, Makowski, Mat, Albert, Jim, Cross, Kaitlyn, Edara, Venkata Viswanadh, Floyd, Katharine, Suthar, Mehul S., Martinez, David R., Baric, Ralph, Buchanan, Wendy, Luke, Catherine J., Phadke, Varun K., Rostad, Christina A., Ledgerwood, Julie E., Graham, Barney S., Beigel, John H.
Format: Artigo
Langue:Inglês
Publié: Massachusetts Medical Society 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7556339/
https://ncbi.nlm.nih.gov/pubmed/32991794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2028436
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires